SCHEMBL28259451

SCHEMBL28259451

NS(=O)(=O)c1cccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)c1

nearest known ligand 0.74

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA1 P00915 7/20 0.74
CA2 P00918 7/20 0.74
NPC1 O15118 1/20 0.62
RAB9A P51151 1/20 0.62
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
ALDH1A1 P00352 1/20 0.62
STAT3 P40763 2/20 0.59
CA9 Q16790 2/20 0.57
POLB P06746 1/20 0.57
CASP6 P55212 1/20 0.57
CTDSP1 Q9GZU7 1/20 0.57
CA12 O43570 1/20 0.56
MAPT P10636 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14372330 0.90 MEN1 (0.76) CA1CA2NPC1RAB9AMEN1
SCHEMBL14372362 0.84 CA1 (0.77) CA1CA2MEN1KMT2AALDH1A1
SCHEMBL28261098 0.80 MAPT (0.69) CA1CA2NPC1RAB9AMEN1
SCHEMBL939934 0.80 CA1 (0.67) CA1CA2NPC1RAB9AMEN1
SCHEMBL13764406 0.79 MEN1 (0.76) CA1CA2NPC1RAB9AMEN1
SCHEMBL14372397 0.79 MEN1 (0.67) CA1CA2NPC1RAB9AMEN1
SCHEMBL14372404 0.79 CA1 (1.00) CA1CA2NPC1RAB9AMEN1
SCHEMBL14372369 0.79 CA1 (0.76) CA1CA2MEN1KMT2ACA9
SCHEMBL14372342 0.79 CA1 (0.71) CA1CA2NPC1RAB9AMEN1
SCHEMBL14372339 0.78 CA2 (0.70) CA1CA2RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108997176-B 4-chloro-N-substituted phenyl-3-sulfonyl aminobenzamide compound, and preparation and anti-tumor application thereof 温州医科大学 2021-07-02 CN disclosed
CN-108997176-A A kind of chloro- N- substituted-phenyl -3- sulphonamidobenzamide class compound of 4- and its preparation and antitumor application thereof 温州医科大学 2018-12-14 CN disclosed